MERIDIAN BIOSCIENCE, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT TIME-BASEDRestricted Stock Unit Award Agreement • November 29th, 2012 • Meridian Bioscience Inc • In vitro & in vivo diagnostic substances
Meridian Bioscience, Inc., an Ohio corporation (the “Company”), grants to the Grantee named below, in accordance with the terms of the Meridian Bioscience, Inc. 2004 Equity Compensation Plan, as Amended and Restated through January 22, 2008 (the “Plan”) and this Restricted Stock Unit Award Agreement (the “Agreement”), the following number of units of Restricted Stock of the Company (the “Restricted Units”), on the Grant Date set forth below:
AMENDED AND RESTATED REVOLVING NOTEMeridian Bioscience Inc • November 29th, 2012 • In vitro & in vivo diagnostic substances
Meridian Bioscience, Inc., an Ohio corporation, Meridian Bioscience Corporation an Ohio corporation (“Corp.”), Omega Technologies, Inc., an Ohio corporation (“Omega”), and Meridian Life Science, Inc., a Maine corporation (collectively and jointly and severally the “Borrowers” and individually a “Borrower”), for value received, hereby promises to pay to the order of FIFTH THIRD BANK (the “Bank”) at its offices, 38 Fountain Square Plaza, Cincinnati, Ohio 45263, in lawful money of the United States of America and in immediately available funds, the principal sum of $30,000,000 or such lesser unpaid principal amount as may be advanced by the Bank pursuant to the terms of the Loan and Security Agreement dated August 1, 2007 by and among the Borrowers and the Bank, as same may be amended from time to time (the “Agreement”). This Note shall mature and be payable in full on September 15, 2015, or such later date as may be determined and agreed upon between Bank and Borrowers pursuant to the Ag
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 29th, 2012 • Meridian Bioscience Inc • In vitro & in vivo diagnostic substances • Ohio
This Third Amendment to Loan and Security Agreement (the “Amendment”) is entered into as of September 15, 2012, by and among Fifth Third Bank, an Ohio banking corporation (the “Bank”) and Meridian Bioscience, Inc., an Ohio corporation (“Parent” or “Agent”), Meridian Bioscience Corporation, an Ohio corporation (“Corp.”), Omega Technologies, Inc., an Ohio corporation (“Omega”) and Meridian Life Science, Inc., a Maine corporation (“MLS”) (collectively, the “Borrowers” and individually a “Borrower”).
